{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058536","form_type":"8-K","ticker":"TRDA","cik":"0001689375","company_name":"Entrada Therapeutics, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.345349+00:00","generated_at":"2026-05-19T13:31:11.384074+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Entrada Therapeutics stockholders elect three Class I directors, ratify auditor","bullets":["Elected Dipal Doshi (27,809,399 for, 429,248 withheld), Kush M. Parmar (24,883,797 for, 3,354,850 withheld), Mary Thistle (27,768,093 for, 470,554 withheld).","Ratified Ernst & Young LLP as independent auditor for FY2025: 30,176,125 for, 74,925 against, 8,476 abstain.","Broker non-votes on director election totaled 2,020,879 shares.","Annual meeting held virtually on June 11, 2025; 30,259,526 shares represented (quorum)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058536","json":"https://secwatch.observer/filing/0001104659-25-058536.json","markdown":"https://secwatch.observer/filing/0001104659-25-058536.md","text":"https://secwatch.observer/filing/0001104659-25-058536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/0001104659-25-058536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/tm2517764d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:31:11.384074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}